Search results for " Services" in Articles / App Notes

Article Hybrid Bioprocessing: A Q&A with Andrew Sinclair
Process Development Forum speaks about hybrid bioprocessing with Andrew Sinclair, President and Founder of BioPharm Services How would you define hybrid bioprocessing? Hybrid processing is n…

Article Designing a Biomanufacturing Facility Incorporating Single-Use Technologies
Asking the right questions is crucial to establishing a facility design. By Peter Genest, John Joseph The benefits of adopting single-use technologies in the production of biopharmaceuticals…

Article CMOs Concerned With Cost of Single-Use Equipment
Suppliers indicate prices for single-use equipment are likely to increase. By Eric Langer Contract manufacturing organizations (CMOs) have been enthusiastic adopters of single-use technologi…

Article Taking a “Development-by-Design” Approach to Cell Therapies
Jun 15, 2015 By Agnes Shanley BioPharm International eBooks Volume 28, Issue 13 Whether outsourcing or developing cell therapies in-house, success demands a focus on quality, c…

Article Continuous Manufacturing: A Changing Processing Paradigm
Apr 01, 2015 By Randi Hernandez BioPharm International Volume 28, Issue 4 Although continuous manufacturing is well established for bulk chemicals, complex automation and validation …

Article Technologies and Practices Must Evolve to Meet Demand
Jan 01, 2015  By Rita Peters Through Dec. 3, 2014, nearly 30% of FDA’s new drug approvals for 2014 were for biologic-based therapies, up from 7% in 2013 (1). As the percentage of large-molecule …

Article Healthcare Reform in China
Chinese healthcare reforms may be a double-edged sword for foreign companies. Sep 1, 2014 By: Jane Wan BioPharm International Volume 27, Issue 9, pp. 8-12  On March 25, 2014, the…

Article Pharma Investments Reflect Key Industry Trends
Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments. Aug 2, 2014 By: Cynthia Challener, PhD Pharmaceutical Technology Volume 37, Iss…

Article Report: Branded Biopharms Most Exposed to Biosimilar Competition
In a new report on the global biosimilar drugs market, Biosimilars: Parsing the Industry's Pipelines, Moody's Investors Service reports that while biosimilar products have been launched in Asia and …

Article The Affordable Care Act's Impact on Innovation in Biopharma
The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare. The Affordable Care Act (ACA) has elicited intense national debate and sent biopharm…

Show All Results

Previous PageNext Page